Home » Mylan Puerto Rico Plant Warned for Skipping Specification Testing
Mylan Puerto Rico Plant Warned for Skipping Specification Testing
The FDA has warned Mylan’s Caguas, Puerto Rico, facility for current good manufacturing practice (cGMP) violations, including a lack of specification testing, for finished drug products.
Generic Line
Generic Line
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May